Gestational Diabetes Mellitus and Iron Supplement; Effects on Pregnancy Outcome

  • Pouya Javadian Mail Maternal-Fetal & Neonatal Research Center & Breastfeeding Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Shohreh Alimohamadi Department of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Mohammad Hadi Gharedaghi Maternal-Fetal & Neonatal Research Center & Breastfeeding Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Sedigheh Hantoushzadeh Maternal-Fetal & Neonatal Research Center & Breastfeeding Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Keywords:
Iron, GDM, Pregnancy, Ferritin

Abstract

The possible effect of iron supplementation has been investigated in the normal population and patients with gestational diabetes mellitus (GDM). In this study, we survey the risk factors of GDM in pregnant women in contrast with normoglycemic patients in a case control study in patients using iron supplement. This case control study conducted on 52 pregnant women with GDM (25 women with type Al and 27 women with Type A2 of GDM). The control group randomly selected 50 normoglycemic women. Venous blood sampling was done between 24 and 28 weeks of pregnancy for measuring of ferritin, lipoproteins, uric acid and malondialdehyde serum levels. Under study variables including age, gestational age, weight and BMI were gathered. All the women were followed up until the time of delivery and pregnancy outcome were gathered. The serum ferritin levels in GDM group was 31.22+15.44, which is significantly higher than 24.76+8.94, in the control group with (P=0.012). Plasma hemogulobin in the control group was 12.2+0.1 compared to 12.9+0.1 in GDM group which was significantly lower (P=0.005). Triglycerides was significantly higher in GDM group in contrast with the control group, 275.08+143.17 and 192.30+92.13 (P=0.001), respectively. Finally, our findings indicate the concentration of serum ferritin levels was significantly higher in The GDM group.

References

Karakash SD, Einstein FH. Diabetes in pregnancy:glycemia control guidelines and rationale. Curr Opin Endocrinol Diabetes Obes 2011;18(2):99-103.

Casanueva E, Viteri FE. Iron and oxidative stress in pregnancy. J Nutr 2003;133(5 suppl 2):1700S-8S.

Stephansson O, Dickman PW, Johansson A, et al. Maternal hemoglobin concentration during pregnancy and risk of stillbirth. JAMA 2000;284(20):2611-7.

Hantoushzadeh S, Javadian P, Salmanian B, et al. Betamethasone effects on the endocervical inflammatory cytokines in preterm labor: a randomized clinical trial. Int Immunopharmacol 2011;11(8):1116-9.

Scholl TO, Hediger ML, Fischer RL, et al. Anemia vs iron deficiency:increased risk of preterm delivery in a prospective study. Am J Clin Nutr 1992;55(5):985-88.

Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002;99(10):3505-16.

Wolf M, Sandler L, Hsu K, et al. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003;26(3):819-24.

Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Crosstalk between iron metabolism and diabetes. Diabetes 2002;51(8):2348-54.

Rajpathak S, Ma J, Manson J, et al. Iron intake and the risk of type 2 diabetes in women:a prospective cohort study. Diabetes Care 2006;29(6):1370-6.

Luan de C, Li H, Li SJ, et al. Body iron stores and dietary iron intake in relation to diabetes in adults in North China. Diabetes Care 2008;31(2):285-6.

Chen X, Scholl TO, Stein TP. Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women:The Camden study. Diabetes Care 2006;29(5):1077-82.

Milman N. Iron and pregnancy--a delicate balance. Ann Hematol 2006;85(9):559-65.

Lachili B, Hininger I, Faure H, et al. Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation. Biol Trace Elem Res 2001;83(2):103-10.

American Diabetes Association. Standards of medical care in diabetes--2007. Diabetes Care 2007;30 (Supp l) 1:S4-S41.

Chan KK, Chan BC, Lam KF, et al. Iron supplement in= pregnancy and development of gestational diabetes--a randomised placebo-controlled trial. BJOG 2009;116(6):789-97.

Scholl TO, Hediger ML. Anemia and iron-deficiency anemia:compilation of data on pregnancy outcome. Am J Clin Nutr 1994;59(2 Suppl):492S-500S.

DeFronzo RA. Lilly lecture 1987. The triumvirate:betacell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37(6):667-87.

Tuomainen TP, Nyyssonen K, Salonen R, et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 1997;20(3):426-8.

Farmer EE, Davoine C. Reactive electrophile species. Curr Opin Plant Biol 2007;10(4):380-6.

Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005;15(4):316-28.

Lao TT, Ho LF. Impaired glucose tolerance and pregnancy outcome in Chinese women with high body mass index. Hum Reprod 2000;15(8):1826-9.

Savvidou M, Nelson SM, Makgoba M, et al. First-trimester prediction of gestational diabetes mellitus:examining the potential of combining maternal characteristics and laboratory measures. Diabetes 2010;59(12):3017-22.

How to Cite
1.
Javadian P, Alimohamadi S, Gharedaghi MH, Hantoushzadeh S. Gestational Diabetes Mellitus and Iron Supplement; Effects on Pregnancy Outcome. Acta Med Iran. 52(5):385-389.
QRcode
Section
Articles